Cost-effectiveness of a potential Zika vaccine candidate: a case study for Colombia
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1741-7015
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Cost-effectiveness of a potential Zika vaccine candidate: a case study for Colombia ; volume:16 ; number:1 ; day:3 ; month:7 ; year:2018 ; pages:1-10 ; date:12.2018
BMC medicine ; 16, Heft 1 (3.7.2018), 1-10, 12.2018
- Creator
-
Shoukat, Affan
- Contributor
-
Vilches, Thomas
Moghadas, Seyed M.
SpringerLink (Online service)
- DOI
-
10.1186/s12916-018-1091-x
- URN
-
urn:nbn:de:101:1-2018090118182909251491
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:33 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Shoukat, Affan
- Vilches, Thomas
- Moghadas, Seyed M.
- SpringerLink (Online service)
Other Objects (12)
A yellow fever–Zika chimeric virus vaccine candidate protects against Zika infection and congenital malformations in mice
Exploring the immunogenicity of an insect-specific virus vectored Zika vaccine candidate
Protective efficacy of a Zika purified inactivated virus vaccine candidate during pregnancy in marmosets
Live Zika virus chimeric vaccine candidate based on a yellow fever 17-D attenuated backbone
Cost-effectiveness analysis of pneumococcal conjugate vaccine 13-valent in older adults in Colombia
Chimeric yellow fever 17D-Zika virus (ChimeriVax-Zika) as a live-attenuated Zika virus vaccine
Current status of Zika vaccine development: Zika vaccines advance into clinical evaluation
Case report: microcephaly associated with Zika virus infection, Colombia
Vaccine Development for Zika Virus—Timelines and Strategies
A Zika virus vaccine expressing premembrane-envelope-NS1 polyprotein
Development of a chimeric Zika vaccine using a licensed live-attenuated flavivirus vaccine as backbone
Computer aided selection of candidate vaccine antigens
A yellow fever–Zika chimeric virus vaccine candidate protects against Zika infection and congenital malformations in mice
Exploring the immunogenicity of an insect-specific virus vectored Zika vaccine candidate
Protective efficacy of a Zika purified inactivated virus vaccine candidate during pregnancy in marmosets
Live Zika virus chimeric vaccine candidate based on a yellow fever 17-D attenuated backbone
Cost-effectiveness analysis of pneumococcal conjugate vaccine 13-valent in older adults in Colombia
Chimeric yellow fever 17D-Zika virus (ChimeriVax-Zika) as a live-attenuated Zika virus vaccine
Current status of Zika vaccine development: Zika vaccines advance into clinical evaluation
Case report: microcephaly associated with Zika virus infection, Colombia
Vaccine Development for Zika Virus—Timelines and Strategies
A Zika virus vaccine expressing premembrane-envelope-NS1 polyprotein
Development of a chimeric Zika vaccine using a licensed live-attenuated flavivirus vaccine as backbone
Computer aided selection of candidate vaccine antigens
A yellow fever–Zika chimeric virus vaccine candidate protects against Zika infection and congenital malformations in mice
Exploring the immunogenicity of an insect-specific virus vectored Zika vaccine candidate
Protective efficacy of a Zika purified inactivated virus vaccine candidate during pregnancy in marmosets
Live Zika virus chimeric vaccine candidate based on a yellow fever 17-D attenuated backbone
Cost-effectiveness analysis of pneumococcal conjugate vaccine 13-valent in older adults in Colombia
Chimeric yellow fever 17D-Zika virus (ChimeriVax-Zika) as a live-attenuated Zika virus vaccine
Current status of Zika vaccine development: Zika vaccines advance into clinical evaluation
Case report: microcephaly associated with Zika virus infection, Colombia
Vaccine Development for Zika Virus—Timelines and Strategies
A Zika virus vaccine expressing premembrane-envelope-NS1 polyprotein
Development of a chimeric Zika vaccine using a licensed live-attenuated flavivirus vaccine as backbone